Sign in
LIXTW Stock Price, Chart, Stats & News
Lixte Biotechnology Holdings, Inc.
Save
Lixte Biotechnology Holdings, Inc. (LIXTW) does not currently pay a dividend.
100,551
Market cap
–
Current P/E
–
Forward P/E
LIXTW chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -76.08% |
ROE | -219.00% |
D/E | – |
Interest coverage ratio | -396.24x |
LIXTW valuation
P/E | – |
P/S | – |
P/B | 3.88x |
P/CF | -7.39x |
P/FCF | -5.45x |
P/OCF | -7.39x |
PEG | -0.54x |
EV multiple | -6.04x |
About
Lixte Biotechnology Holdings, Inc. functions as a biopharmaceutical firm dedicated to the discovery and development of innovative therapeutic compounds. The company leverages advanced biomarker technology to create novel drug candidates aimed at combating severe and widespread human diseases. Its core research primarily concentrates on protein phosphatase inhibitors, which are being explored for standalone administration or in conjunction with cytotoxic agents, radiation therapy, and immune checkpoint blockers.
Similar securities
Based on sector and market capitalization
Report issue